Home › Eli Lilly to stop study of heart disease drug evacetrapib
 

Keywords :   


Eli Lilly to stop study of heart disease drug evacetrapib

2015-10-12 18:15:55| Biotech - Topix.net

Shares of Eli Lilly plunged Monday after the drugmaker said it would stop developing a heart disease treatment that had advanced deep into clinical testing. The Indianapolis company said researchers cited a lack of effectiveness, not safety concerns, in recommending an end to late-stage research on the drug, evacetrapib.

Tags: study stop heart drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.09AWA releases Glue-Applied Label Market Report 2024
23.09Hurricane John Graphics
23.09Hurricane John Forecast Discussion Number 5
23.09Hurricane John Wind Speed Probabilities Number 5
23.09Eastern North Pacific Tropical Weather Outlook
23.09Hurricane John Forecast Advisory Number 5
23.09Hurricane John Public Advisory Number 5
23.09Potential Tropical Cyclone Nine Public Advisory Number 1A
More »